Structure-based design of a novel series of potent, selective inhibitors of the class I phosphatidylinositol 3-kinases

J Med Chem. 2012 Jun 14;55(11):5188-219. doi: 10.1021/jm300184s. Epub 2012 May 23.

Abstract

A highly selective series of inhibitors of the class I phosphatidylinositol 3-kinases (PI3Ks) has been designed and synthesized. Starting from the dual PI3K/mTOR inhibitor 5, a structure-based approach was used to improve potency and selectivity, resulting in the identification of 54 as a potent inhibitor of the class I PI3Ks with excellent selectivity over mTOR, related phosphatidylinositol kinases, and a broad panel of protein kinases. Compound 54 demonstrated a robust PD-PK relationship inhibiting the PI3K/Akt pathway in vivo in a mouse model, and it potently inhibited tumor growth in a U-87 MG xenograft model with an activated PI3K/Akt pathway.

MeSH terms

  • Animals
  • Biological Availability
  • Class I Phosphatidylinositol 3-Kinases / antagonists & inhibitors*
  • Class I Phosphatidylinositol 3-Kinases / physiology
  • Crystallography, X-Ray
  • Drug Design
  • Female
  • Humans
  • Indazoles / chemical synthesis
  • Indazoles / pharmacokinetics
  • Indazoles / pharmacology
  • Mice
  • Mice, Nude
  • Microsomes, Liver / metabolism
  • Models, Molecular
  • Piperazines / chemical synthesis*
  • Piperazines / pharmacokinetics
  • Piperazines / pharmacology
  • Proto-Oncogene Proteins c-akt / physiology
  • Purines / chemical synthesis
  • Purines / pharmacokinetics
  • Purines / pharmacology
  • Pyrazoles / chemical synthesis
  • Pyrazoles / pharmacokinetics
  • Pyrazoles / pharmacology
  • Pyridines / chemical synthesis*
  • Pyridines / pharmacokinetics
  • Pyridines / pharmacology
  • Pyrimidines / chemical synthesis
  • Pyrimidines / pharmacokinetics
  • Pyrimidines / pharmacology
  • Rats
  • Signal Transduction
  • Structure-Activity Relationship
  • Sulfonamides / chemical synthesis*
  • Sulfonamides / pharmacokinetics
  • Sulfonamides / pharmacology
  • Sulfones / chemical synthesis
  • Sulfones / pharmacokinetics
  • Sulfones / pharmacology
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • Triazines / chemical synthesis*
  • Triazines / pharmacokinetics
  • Triazines / pharmacology
  • Xenograft Model Antitumor Assays

Substances

  • 4-(2-((6-methoxypyridin-3-yl)amino)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine
  • Indazoles
  • Piperazines
  • Purines
  • Pyrazoles
  • Pyridines
  • Pyrimidines
  • Sulfonamides
  • Sulfones
  • Triazines
  • Class I Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases